Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Gold (elemental symbol Au) is a yellow metallic element that has been used in medicine primarily as part of complex compounds known as "gold salts" or "gold-containing drugs." These compounds have historically been used for the treatment of rheumatoid arthritis and other inflammatory conditions. The use of elemental or ionic gold in medicine is referred to as chrysotherapy or aurotherapy. Gold itself is not administered directly; rather, its pharmaceutical application comes through compounds such as sodium aurothiomalate (for injection) and auranofin (oral). The mechanism by which these gold compounds exert their anti-inflammatory effects remains unclear but may involve modulation of immune responses and inhibition of inflammatory cytokines. Use has declined due to significant side effects, slow onset, and the advent of safer alternatives like methotrexate[1][2][3][6][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on gold.